Alternatives to Curesponse

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Unleashing the power of genomics at scale for biological advances and human health.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

AI-driven digital twin of embryo development for cell-based therapies.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Biotechnology company developing novel therapies for multiple myeloma.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Digital pathology imaging technology and AI-driven precision pathology software.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Global life sciences company providing diagnostic and biopharma laboratory services.

Develops a computational model of the human body for drug discovery and development.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Alvox Bio is a life sciences startup developing novel therapeutic antibodies.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.